4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-329694
Chief Executive Officer acquired 84,810 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Collard Craig A · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-30 | Exercise or conversion : show line 1 in the form | +50,021 | 821,703 | D |
| 2026-07-31 | Exercise or conversion : show line 2 in the form | +34,789 | 856,492 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −50,021 | 700,295 | D |
| 2026-07-31 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −34,789 | 347,886 | D |
Loading xslF345X06/ownership.xml…